Interlaboratory variations of fluoroquinolone susceptibility testing: An international study to validate the quality of microbiology results reported during the fleroxacin clinical trials
- 31 October 1993
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 17 (3) , 225-232
- https://doi.org/10.1016/0732-8893(93)90101-c
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Prospects for standardisation of methods and guidelines for disc susceptibility testingEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- European standards for antibiotic susceptibility testing: Towards a theoretical consensusEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agentsPublished by Elsevier ,1989
- RO 23-6240 (AM-833), a new fluoroquinolone: In vitro antimicrobial activity and tentative disk diffusion interpretive criteriaDiagnostic Microbiology and Infectious Disease, 1987
- In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivativeAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of Ro 23-6240, a new fluorinated 4-quinoloneAntimicrobial Agents and Chemotherapy, 1986
- An antibiotic susceptibility testing trial organised as part of the United Kingdom national external microbiological quality assessment scheme.Journal of Clinical Pathology, 1982
- Susceptibility Tests of Anaerobic Bacteria: Statistical and Clinical ConsiderationsThe Journal of Infectious Diseases, 1974